Form 4: ClearPoint Neuro COO Mazin Sabra Reports Stock Transactions
SEC Form 4 Filing
ClearPoint Neuro's Chief Operating Officer, Mazin Sabra, reports the acquisition and disposal of common stock related to the settlement of restricted stock units.
Summary
- Mazin Sabra, the Chief Operating Officer of ClearPoint Neuro, Inc. (CLPT), reported transactions involving the company's common stock on March 12, 2025.
- Sabra acquired 13,050 shares of common stock through the settlement of restricted stock units (RSUs).
- Simultaneously, Sabra disposed of 6,627 shares to cover tax withholding obligations at a price of $13.18 per share.
- Following these transactions, Sabra directly owns 51,203 shares of ClearPoint Neuro common stock and 52,202 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions related to executive compensation.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings to understand management's sentiment and potential future actions.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of stock transactions (acquisition and disposal). |
| 03/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.